Amezinium metilsulfate
Jump to navigation
Jump to search
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Physiological data | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H15N3O5S |
| Molar mass | 313.32 g/mol |
| 3D model (JSmol) | |
| |
| |
| Template:Xmark | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Amezinium metilsulfate (INN, trade name Regulton) is a sympathomimetic drug used for the treatment of low blood pressure. It has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.
References
Categories:
- Articles with short description
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- Articles with changed EBI identifier
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- Cardiovascular Drugs
- Drug
